Looking For A Higher-Sensitivity Measure of Protein Biomarkers?

Simoa® digital immunoassay technology is transforming the study of neurology, infectious disease, oncology, and other research areas by enabling researchers to examine critical proteins at ultra-low – even baseline – levels, in most non-invasive sample types. Simoa allows researchers to expand the limits of biomarker research by measuring single or multiplex targets at femtogram levels in record time.